The combination of Letrozole and trastuzumab as first line or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570291225975891840
  • NII Article ID
    10025714111
  • Data Source
    • CiNii Articles

Report a problem

Back to top